This article explores the presence of tryptamines classified as NPS among the substances delivered for analysis to a harm-reduction organization, to describe the substances found in the samples after analysis, and to compare analytical results of regulated vs. non-regulated tryptamines. It argues that there is a need for further research in order to prevent the potential health risks associated with their use.
ResearchTags
2C-C 4-FA 4-FMP 25C-NBOMe adulteration alcohol Alert alprazolam amantadine antihistamine mixture cannabis cryptomarkets cyproheptadine deep web doxepin drug checking service drug testing ecstasy Encryption ephylone Etizolam fentanyl fentanyl derivatives festival flualprazolam flubromazolam GPG harm reduction heroin International Energy Control intoxication legal matters LSD mail MDMA methamphetamine N-Ethyl-Pentylone NBOME NPS party pills poisoning preservative psychedelic xanax
Recent posts
- Important update about GPG 4 October, 2022
- Important information about shipments 24 December, 2021
- Recent Adware Attack on site 16 December, 2020
- Back in Business & Overhaul 4 June, 2020
- Drug Crypto Markets at CND63 27 March, 2020
- Update regarding COVID-19 23 March, 2020